| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Division of Hematology/Oncology, Cedars-Sinai Research Institute, University of California at Los Angeles School of Medicine, Los Angeles, California 90048 [S. T., M. K., S. P., H. E. T., H. P. K.]; Institute of Human Genetics, University of Heidelberg, D-69120 Heidelberg, Germany [T. S., C. R. B.]; Department of Pediatrics IV, Hannover Medical School, D-3000 Hannover, Germany [M. S., A. R.]; and Department of Internal Medicine, Kochi Medical School, Kochi 783, Japan [I. K., I. M.]
Cytogenetic analysis of childhood acute lymphoblastic leukemia (ALL) identified nonrandom chromosomal abnormalities of the long arm of chromosome 6. Most of the alterations are deletions that are thought to be indicative of the presence of a tumor suppressor gene that is mutated on the remaining allele. These observations led us to consider whether 6q loss may contribute to the pathogenesis of childhood ALL. To define further a region containing this gene, we analyzed the loss of heterozygosity (LOH) of chromosome 6 in 113 primary ALL samples with matched normal DNA using 34 highly informative microsatellite markers. LOH was found in 17 (15%) samples at one or more of the loci, and partial or interstitial deletions of 6q were detected in 11 of these tumors. On the basis of these results, we performed a detailed deletional map and identified two distinct regions of deletion. The first region is flanked by D6S283 and D6S302 loci at 6q2122. The second region is flanked by D6S275 and D6S283 loci at 6q21. Clinical analysis determined that LOH of 6q was demonstrated both in precursor-B cell ALLs (15 of 93; 16%) and in T cell ALLs (2 of 19; 11%). In addition, 19 patients have been studied at diagnosis and relapse; 18 showed the same 6q2122 structural abnormality at relapse (normal, 16 patients; LOH, 2 patients) as their initial presentation, suggesting, albeit with a small patient sample size, that 6q2122 deletions may be an initial event in leukemogenesis and may occur less frequently during the progression of childhood ALL. These data suggest the presence of putative tumor suppressor genes on chromosome arm 6q that are important in the development of both T and precursor-B childhood ALLs. Our map provides important information toward cloning putative ALL tumor suppressor genes.
1 Supported in part by NIH grants, the Concern Foundation, the Parker Hughes Trust (to H. P. K.), the Deutsche Forschungsgemeinschaft, Deutsche Krebshilfe (to C. R. B.), and a grant-in-aid from the Ministry of Education, Science, Sports, and Culture of Japan (to S. T.).
2 To whom requests for reprints should be addressed, at Department of Internal Medicine, Kochi Medical School, Okohcho, Nankoku, Kochi 783, Japan. Phone: 81-888-80-2345; Fax: 81-888-80-2348.
Received 10/21/97. Accepted 4/10/98.
This article has been cited by other articles:
![]() |
S. P. Treon, Z. R. Hunter, A. Aggarwal, E. P. Ewen, S. Masota, C. Lee, D. D. Santos, E. Hatjiharissi, L. Xu, X. Leleu, et al. Characterization of familial Waldenstrom's macroglobulinemia Ann. Onc., March 1, 2006; 17(3): 488 - 494. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. P. Wittschieben, S. C. Reshmi, S. M. Gollin, and R. D. Wood Loss of DNA Polymerase {zeta} Causes Chromosomal Instability in Mammalian Cells Cancer Res., January 1, 2006; 66(1): 134 - 142. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. B. Sinclair, A. Sorour, M. Martineau, C. J. Harrison, W. A. Mitchell, E. O'Neill, and L. Foroni A Fluorescence in Situ Hybridization Map of 6q Deletions in Acute Lymphocytic Leukemia: Identification and Analysis of a Candidate Tumor Suppressor Gene Cancer Res., June 15, 2004; 64(12): 4089 - 4098. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Barghorn, E. J. M. Speel, B. Farspour, P. Saremaslani, S. Schmid, A. Perren, J. Roth, P. U. Heitz, and P. Komminoth Putative Tumor Suppressor Loci at 6q22 and 6q23-q24 Are Involved in the Malignant Progression of Sporadic Endocrine Pancreatic Tumors Am. J. Pathol., June 1, 2001; 158(6): 1903 - 1911. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Jackson, P. Carrara, V. Duke, P. Sinclair, M. Papaioannou, C. J. Harrison, and L. Foroni Deletion of 6q16-q21 in Human Lymphoid Malignancies: A Mapping and Deletion Analysis Cancer Res., June 1, 2000; 60(11): 2775 - 2779. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Starostik, A. Greiner, A. Schultz, A. Zettl, K. Peters, A. Rosenwald, M. Kolve, and H. K. Muller-Hermelink Genetic aberrations common in gastric high-grade large B-cell lymphoma Blood, February 15, 2000; 95(4): 1180 - 1187. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Hatta, Y. Yamada, M. Tomonaga, I. Miyoshi, J. W. Said, and H. P. Koeffler Detailed Deletion Mapping of the Long Arm of Chromosome 6 in Adult T-Cell Leukemia Blood, January 15, 1999; 93(2): 613 - 616. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |